Oxaliplatin with high-dose leucovorin (LV) and 5-Fluorouracil (5FU) 48-hour infusion in pretreated metastatic colorectal cancer (FOLFOX6)

被引：0
|
作者：
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles-Amar, V
Izrael, V
Krulik, M
机构：
[1] Hop St Antoine, GERCOR, F-75012 Paris, France
[2] Hop Tenon, F-75020 Paris, France
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
173P
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] 5-FLUOROURACIL PLUS HIGH-DOSE LEUCOVORIN FOR THERAPY OF 5-FLUOROURACIL-RESISTANT METASTATIC COLORECTAL-CANCER
    OSTERWALDER, B
    SCHMID, L
    JUNGI, WF
    SENN, HJ
    BLUT, 1988, 57 (04): : 207 - 207
  • [42] Cost-effectiveness of oxaliplatin/5FU/LV (FOLFOX) vs. irinotecan/5FU/LV (IFL) as first-line treatment of metastatic colorectal cancer
    Aballea, S.
    Najib, M.
    Cure, S.
    O'Neil, B.
    ANNALS OF ONCOLOGY, 2006, 17 : 66 - 66
  • [43] Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
    Pectasides, D
    Pectasides, A
    Farmakis, D
    Bountouroglou, N
    Nikolaou, M
    Koumpou, M
    Mylonakis, N
    Kosmas, C
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 537 - 542
  • [44] Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer
    Lin, YC
    Chen, JS
    Wang, CH
    Wang, HM
    Chang, HK
    Liau, CT
    Yang, TS
    Liaw, CC
    Liu, HE
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 605 - 609
  • [45] Suramin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in metastatic colorectal cancer patients resistant to 5-FU+LV-based chemotherapy
    Falcone, A
    Pfanner, E
    Brunetti, I
    Allegrini, G
    Lencioni, M
    Galli, C
    Masi, G
    Danesi, D
    Antonuzzo, A
    Del Tacca, M
    Conte, PF
    TUMORI, 1998, 84 (06) : 666 - 668
  • [46] High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)
    Maindrault-Goebel, F
    de Gramont, A
    Louvet, C
    André, T
    Carola, E
    Mabro, M
    Artru, P
    Gilles, V
    Lotz, JP
    Izrael, V
    Krulik, M
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) : 1000 - 1005
  • [47] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Anselmi, E
    Bidin, L
    Palladino, M
    Rodinò, C
    ANNALS OF ONCOLOGY, 2005, 16 : 323 - 323
  • [48] Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience
    Wang, WS
    Chen, PM
    Chiou, TJ
    Liu, JH
    Lin, JK
    Lin, TC
    Chen, WS
    Jiang, JK
    Yen, CC
    Fan, FS
    Hsieh, RK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (01) : 16 - 19
  • [49] A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    Gennatas, C.
    Papaxoinis, G.
    Michalaki, V.
    Mouratidou, D.
    Andreadis, Ch.
    Tsavaris, N.
    Pafiti, A.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (05) : 538 - 544
  • [50] A phase I and pharmacokinetic study of weekly 48-hour infusion of high-dose 5-Fluorouracil and folinic acid in patients with recurrent or metastatic colorectal cancers.
    Yeh, KH
    Lu, WC
    Ho, YF
    Lu, YS
    Hsu, CH
    Liu, MY
    Chen, RR
    Cheng, AL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 287S - 287S
12345